Skip to main content
. 2020 May 12;96(3):708–717. doi: 10.1111/php.13267

Figure 3.

Figure 3

Kinetic patterns of uptake of the cetuximab–IR700DX conjugate by the OSC19 tumor and its surrounding normal blood vessels and connective tissue in the skin‐fold window chamber at various times after i.v. injection. The amounts of the conjugate in the tissues were measured by quantifying the fluorescent signals of the conjugate IR700DX with the intravital LSM as described in the Section of Materials and Methods.